Logo-jcvtr
Submitted: 05 Jan 2023
Accepted: 05 Jan 2023
First published online: 16 Mar 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Abstract View: 292
PDF Download: 226
Full Text View: 41
J Cardiovasc Thorac Res. 15(1):67. doi: 10.34172/jcvtr.2023.31706

Letter to Editor

Contrast-induced nephropathy prediction following ST-elevation myocardial infarction: Missing links

Rohan Magoon 1ORCID logo, Brajesh Kaushal 2, *ORCID logo
1Department of Anaesthesi, Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr. Ram Manohar Lohia Hospital, Baba Kharak Singh Marg, New Delhi-110001, India
2Department of Anaesthesia, Gandhi Medical College and Hamidia Hospital, Bhopal 462001, Madhya Pradesh, India
*Corresponding Author: Brajesh Kaushal, Email: brajeshkaushal3@gmail.com

Abstract

Keywords:

Copyright

© 2023 The Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Dear Editor,

The study by Ceylan and Yildirim outlining H2FPEF score as independent predictor of contrast-induced nephropathy (CIN) in ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI), emerges as an exemplary research work.1 Nonetheless, considering the relevance of the research subject, additional insights into the topic would certainly interest the Journal readership.

The authors retrospectively analyze the data of 355 patients, wherein one misses a comparative account of the serum albumin (SA) levels in the cohort developing CIN (n = 63) as opposed to those without CIN (n = 292).1 The importance of the former is heralded by the Wiedermann et al meta-analysis suggesting a causal association between hypoalbuminemia and acute kidney injury (AKI), emanating from a total of 43 studies and 68,262 subjects.2 Notably so, the meta-analysis included 8 studies with 4,344 patients combined from either cardiac surgical or PCI settings.2

More importantly, Murat et al retrospectively delineate significantly lower SA in their acute coronary syndrome (ACS) patients with contrast-induced AKI, or CI-AKI (n = 107) compared to those with normal renal function following PCI (n = 783) (3.52 ± 0.40 v/s 3.94 ± 0.39 mg/dL, P < 0.001).3 Subsequent to a multivariate analysis, the group highlights SA as an independent CI-AKI predictor (OR; 95% CI: 0.177; 0.080-0.392, P < 0.001) in a research scenario demonstrating peculiar similarities to the Ceylan and Yildirim study.1,3

Ahead of the well-known pro-inflammatory links of both hypoalbuminemia and AKI, Wei et al elucidate a pivotal role of nutritional status in determining the eventual risk to contrast-induced renal injury in an elderly subset undergoing PCI.2-5 Indeed, the dual relationship of SA with malnutrition and inflammation cannot be overemphasized, particularly in advanced age.3,5 Moreover, whilst the inclusion of SA could have augmented the contextual research lucidity, the optimal CIN-predictive cut-off of the H2FPEF score might also require further consolidation given the recent literature in the subject (H2FPEF cut-off of 2.5 predicting CIN in ACS patients with 79.8% and 64.1% sensitivity-specificity in Ozbeyaz et al study vis-à-vis a CIN-predictive cut-off of 1.5 emanating from the Ceylan and Yildirim study and demonstrating a sensitivity-specificity of 64.0% and 72.1% in an exclusive STEMI cohort).1,6


Competing Interests

Nothing to declare.


References

  1. The relationship between H2FPEF score and contrast induced nephropathy in patients with ST elevation myocardial infarction. J Cardiovasc Thorac Res 2022; 14(4):240-5. doi: 10.34172/jcvtr.2022.30537 [Crossref]
  2. Causal relationship between hypoalbuminemia and acute kidney injury. World J Nephrol 2017; 6(4):176-87. doi: 10.5527/wjn.v6.i4.176 [Crossref]
  3. Impact of serum albumin levels on contrast-induced acute kidney injury in patients with acute coronary syndromes treated with percutaneous coronary intervention. Angiology 2015; 66(8):732-7. doi: 10.1177/0003319714551979 [Crossref]
  4. Nitric oxide: renoprotective in cardiac surgery!. Braz J Cardiovasc Surg 2020; 35(4):602-3. doi: 10.21470/1678-9741-2020-0080 [Crossref]
  5. Nutritional status and risk of contrast-associated acute kidney injury in elderly patients undergoing percutaneous coronary intervention. Clin Exp Nephrol 2021; 25(9):953-62. doi: 10.1007/s10157-021-02061-4 [Crossref]
  6. H2FPEF score and contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Angiology 2023; 74(2):181-8. doi: 10.1177/00033197221099425 [Crossref]